| Detected | Trial | Change |
|---|---|---|
| 2026-08-07 | NCT07438067 EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation |
Phase changed: Phase 1/2 -> Phase 1 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07648992 | Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor… | Hematopoietic Stem Cell Transplantation | Recruiting |
| Phase 2 | |||
| NCT07321301 | Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory… | B-cell Lymphoma Refractory | Recruiting |
| NCT07340723 | Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease ) | GVHD,Acute | Recruiting |
| NCT07489534 | Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal… | Multiple Myeloma | Recruiting |
| NCT07489989 | Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor… | Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) | Recruiting |
| NCT07509749 | Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease) | GVHD, Acute | Recruiting |
| NCT07094477 | Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma | Lymphoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT07368634 | Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic… | Epstein-Barr Virus Infection | Recruiting |
| NCT07450391 | EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders | Epstein-Barr Virus-Associated Lymphoproliferative Disorders | Recruiting |
| Phase 1 | |||
| NCT07438067 | EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation | EBV-DNA Viremia | Recruiting |
| NCT07094464 | Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After… | TP53-mutated MDS and AML | Active, Not Recruiting |
| NCT07576010 | Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute… | Acute Graft-versus-host Disease | Active, Not Recruiting |